WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001085193) METHOD FOR PROMOTING NEOVASCULARIZATION USING A TWEAK AGONIST AND AN ANGIOGENIC FACTOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/085193    International Application No.:    PCT/US2001/014545
Publication Date: 15.11.2001 International Filing Date: 07.05.2001
Chapter 2 Demand Filed:    05.12.2001    
IPC:
A61K 38/18 (2006.01), A61K 38/22 (2006.01), A61K 45/00 (2006.01), A61P 1/04 (2006.01), A61P 17/02 (2006.01), A61P 3/10 (2006.01), A61P 41/00 (2006.01), A61P 43/00 (2006.01), A61P 9/00 (2006.01), A61P 9/10 (2006.01), A61P 9/14 (2006.01), C12N 5/071 (2010.01)
Applicants: BIOGEN, INC. [US/US]; 14 Cambridge Center, Cambridge, MA 02142 (US) (AE, AG, AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW only).
JAKUBOWSKI, Aniela [US/US]; (US) (For US Only).
BURKLY, Linda [US/US]; (US) (For US Only)
Inventors: JAKUBOWSKI, Aniela; (US).
BURKLY, Linda; (US)
Agent: LINKKILA, Timothy, P.; Biogen, Inc., 14 Cambridge Center, Cambridge, MA 02142 (US)
Priority Data:
60/202,738 08.05.2000 US
Title (EN) METHOD FOR PROMOTING NEOVASCULARIZATION USING A TWEAK AGONIST AND AN ANGIOGENIC FACTOR
(FR) PROCEDE SERVANT A FAVORISER LA NEOVASCULARISATION
Abstract: front page image
(EN)The present invention relates to a method for enhancing angiogenic activity to promote neovascularization comprising administering to a subject a formulation comprising a synergistically effective amount of a TWEAK agonist and an angiogenic factor.
(FR)Cette invention se rapporte à un procédé d'accroissement de l'activité angiogénique destiné à favoriser la néovascularisation et consistant à cet effet à administrer à un sujet une formulation contenant une quantité à effet synergique d'un agoniste TWEAK et d'un facteur angiogénique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)